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Abstract 
Development of chronic tophaceous arthritis with marked joint impairment may follow repeated acute attacks. We 
present a 60 year-old man with huge urate deposits and severe gouty arthropathy with underlying hypothyroidism. 
During the past years, he had undergone several surgeries with different degrees of amputation to remove the 
tophus. Magnetic resonance spectroscopy (MRS) of foot finger revealed high peak of lactate, suggesting that high 
lactate levels is linked with chronic gout and frequent attacks. The patient was treated with levothyroxine along 
with gout medication, and his thyroid-stimulating hormone (TSH) and urate levels were soon normal, suggesting 
that the underlying hypothyroidism had aggravated his gout condition. 
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Introduction1 
Gout is a metabolic disease that can manifest as 
acute arthritis or chronic arthropathy, which is 
also called tophaceous gout, and deposition of 
monosodium urate crystals in joint, bones, 
connective tissue, and kidneys.1,2 All patients with 
gout have hyperuricemia at some point of their 
disease, and this elevated uric acid levels are 
linked with urate crystal formation, which is the 
underlying pathology for gout.3 
Development of chronic tophaceous arthritis 
with marked joint impairment may follow 
repeated acute attacks and this might be 
aggravated with existing comorbidities such as 
thyroid problems. Some studies have shown that 




untreated thyroid disorders may promote 
hyperuricemia as thyroid hormone increases 
serum urate levels through regulation of 
glomerular filtration rate.4 
Many studies have shown that certain imaging 
techniques are useful in detecting urate 
deposition even prior to the first clinical 
symptoms, and thus, can be used to evaluate the 
extent of deposition and provide objective 
measurement of crystal depletion during urate-
lowering treatment.5 Magnetic resonance 
spectroscopy (MRS), however, has never been 
used in this regard. We present a patient with 
huge urate deposits and severe gouty arthropathy 
resistant to treatment. 
Case Report 
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resistant case of tophaceous gout. He had been 
diagnosed with gout several years ago and had 
been treated with allopurinol 100 mg/day and 
colchicine 0.5 mg/day for a long time. On 
laboratory examination, slightly elevated uric acid 
(10.6 mg/l) was attributed to untreated 
hypothyroidism. In addition to hypothyroidism, 
he had a positive history of ischemic heart disease 
and mild hypertension. Cardiac stress test had 
revealed mild stress-induced ischemia in apex. 
He had a normal left ventricular ejection fraction 
of 50% associated with trivial mitral and tricuspid 
regurgitation in echocardiography. Coronary 
angiography detected one-vessel disease (1-VD). 
He was, thus, treated with various anti-
hypertensive drugs.  
During the course of many years, he has had 
multiple acute gout flares, resulting in the 
development of multiple tophi localized to his 
feet. He had undergone several surgeries because 
of these tophi, which resulted in the amputation 
of his right big toe. As for his left foot, similarly, 
the tophus located on the lateral malleolus was 
excised. In a recent surgery, a tophus on the 
dorsal aspect of the extensor tendon extended to 
the plantar surface was excised as possible. The 
very tophus had caused erosion of second to fifth 
metatarsal bones to some extend; however, none 
of them were fractured.  
He was noted to have a multilobular, solid, 
tender, enlarged subcutaneous nodule of the 
distal metatarsal of right big toe, causing severe 
deformation (Figure 1). There was also a small 
tophus on his right ear. The tophus on the big toe 
had progressively increased in size and had 
limited his movements to the point that he could 
barely walk unaided. He was told that at this 
stage no medication or surgery could help him. 
Physical examination disclosed an obese man, 
with no goiter, and marked deformities of feet.  
Laboratory evaluation revealed a serum uric 
acid level of 10.6 mg/dl. Erythrocyte 
sedimentation rate had increased to 37 mm/h. 
Serum creatinine was 1.36 mg/dl and fasting 
blood sugar was 107 mg/dl. Urinary protein was 
2.28 g/day. Thyroid-stimulating hormone (TSH) 
was 40.1 μUI/ml, T4 and T3 were 1.7 ng/dl and 
0.7 pg/ml, respectively. Liver function test was 
also performed, and the results were 
unremarkable. Kidney ultrasound and cardiac 




Figure 1. Multilobular, solid, tender, enlarged 
subcutaneous nodule of the distal metatarsal of right 
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Considering the unusual size of the tophus 
and its resistant nature, diagnostic arthrocentesis 
was performed and yielded white, chalky 
particulate material. Light microscopy of 
Hematoxylin and Eosin-stained smears disclosed 
amorphous material (urate crystals) surrounded 
by inflammatory giant cells on histopathologic 
examination (Figure 2). Calcium-containing 
compounds or apatite crystals were not found. 
 
 
Figure 2. Hematoxylin and eosin-stained smears 
disclosed amorphous material (urate crystals) 
surrounded by inflammatory giant cells on 
histopathologic examination 
 
The radiographic examination of the feet 
showed eccentric soft tissue thickening in the 
absence of any calcifications or ossifications and 
well-defined intra- and extra-articular bone 
destruction. The first metatarsophalangeal joints 
of the feet seemed to have disappeared. Tars 
metatarsal joints of the third, fourth, and fifth rays 
were also destroyed. 
These findings led to magnetic resonance 
imaging (MRI) studies, obtained with a 1.5 T 
magnetom (Siemens, Munich, Bavaria, Germany), 
which revealed a well-defined soft tissue 
abnormality of intermediate signal on T1 
weighting and of intermediate to low intensity on 
T2 weighting (Figure 3). In the obtained images, 
there was soft tissue expansion containing tiny 
calcified tophi adjacent to distal phalanx of toe 
without evident bony destruction. On the 
obtained multiplanar MR images of right foot, 
there was soft tissue expansion with low signal in 
T1 and high signal in T2 weighted images 
without evident phalangeal destruction. 
The MRS of toe revealed high peak of lactate in 
the 1 ppm region of curve (Figure 4). Cho-Cr and 
NAA levels were in normal range.  
Due to his huge urate deposits, allopurinol 
dose was gradually increased to 200 mg/day with 
prophylactic colchicine. Low dose indomethacin 
was also prescribed to reduce marked joint 
inflammation. He was initially treated with 
thyroid hormone (25 μg/day), which was 
gradually increased to 200 μg/day, based on TSH 
levels. As a result, serum TSH and urate 
progressively decreased to normal levels. 
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Figure 4. Magnetic resonance imaging (MRS) of right toe 
 
Discussion 
Gout, one of the several crystal arthritides, is 
caused by persistent chronic hyperuricemia. It is 
characterized clinically by relapsing and 
remitting attacks of joint pain and swelling, 
usually monoarticular, and monosodium urate 
crystal deposition (tophi), typically found in and 
around joints on fingers, toes, wrists, and knees, 
on the olecranon bursae, on the Achilles tendons 
and rarely on the helix of the ears, the sclerae, 
subconjunctivally, and on the cardiac valves.6-8 
The development of these chalky-appearing 
tophaceous deposits generally occurs several 
months to years after the episodic arthritic attacks 
and may not be recognized by the patient as soft-
tissue tophi and may be painless and nontender.9 
Gout can coexist with many diseases such as 
thyroid problems.10 Both hyperthyroidism and 
hypothyroid states are reported to be associated 
with gout and hyperuricemia.11 Many studies 
have linked long-standing hypothyroidism with 
several biochemical abnormalities, including 
increased serum creatinine and uric acid levels.12 
Hyperuricemia, in these cases, is believed to be 
secondary to increased production due to 
myopathy associated with hypothyroidism or 
decreased renal plasma flow and impaired 
glomerular filtration.13 High TSH levels were 
similarly a complicating factor in our patient. In 
our patient, similarly, treating the underlying 
hypothyroidism was associated with reduced 
uric acid levels (serum uric acid = 9.4 mg/dl; 
urine uric acid = 250 µmol/l). This illustrates the 
need to screen patients with gout and even 
asymptomatic hyperuricemia and joint pain for 
underlying hypothyroidism. 
Generally, the clinical diagnosis of gouty 
tophus is easily rendered, even in the absence of 
pathologic material, if the classic clinical and 
radiologic features are present. Fine-needle 
aspiration biopsy (FNAB) can be extremely 
helpful and yield diagnostic findings in 
distinguishing gout from pseudogout. Polarizing 
microscopy using red filter is, therefore, 
necessary to establish a correct diagnosis.14 
Histopathologic studies, on the other hand, show 
aggregates of urate crystals with surrounding 
macrophages, lymphocytes, and giant cells.15 
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including soft tissue swelling, bony erosion, and 
solid soft tissue masses (tophi) are not entirely 
specific and may be seen in a variety of benign 
and malignant disorders.16,17 Calcifications as well 
as ossification may be present. 
Traditionally, tophi was detected and 
monitored by palpation, or by standard 
radiography or ultrasonography. Reports suggest 
that radiography may underestimate the size of 
and extent of soft tissue and osseous tophi, while 
a recent ultrasonography study characterized 
tophi as compared to nodules or lipomas and 
cysts.18,19 MRI has been shown to be a more 
sensitive, accurate, and reproducible technique to 
measure tophus volume and consequently 
monitor the efficacy of long-term urate-lowering 
therapy in patients with tophaceous  
gout.20,21 
Although the evaluation of tophi using FNAB, 
CT-scan, ultrasound, and MRI has been described 
as a potential diagnostic aid, to our knowledge, 
there is no report of MRS in this regard. MRS is a 
noninvasive diagnostic test for measuring 
biochemical changes in different tissues. While 
MRI identifies the anatomical location of a mass, 
MRS compares the chemical composition of 
normal tissue with abnormal tissue. This test can 
also be used to detect tissue changes in different 
diseases. There are several different metabolites 
or products of metabolism that can be measured 
to detect the chemical composition of a tissue; 
amino acids, lipid, lactate, alanine,  
n-acetylaspartate (NAA), choline, creatinine, and 
myo-inositol. Choline (Cho) is the precursor to 
acetylcholine and cell membrane components. In 
MRS, it is a marker of cellular membrane 
turnover and is, therefore, elevated in neoplasms, 
demyelination, and gliosis. Creatinine (Cr), which 
is commonly found in metabolically active tissues 
(brain, muscle, heart), is important in storage and 
transfer of energy. The creatinine level tends to be 
maintained at a relatively constant level, and 
thus, is predominantly used as a convenient 
internal standard. NAA is an acetylated amino 
acid which is found in high concentrations in 
neurons and is a marker of neuronal viability. 
The reduced NAA levels show the processes that 
destroy neurons. Lactate (Lac) is the marker of 
anaerobic metabolism (no peak is seen in normal 
spectra). It is, therefore, elevated in necrotic areas, 
infections, and inflammatory infiltrates. The high 
lactate peak in our patient illustrates the 
inflammatory nature of the mass. 
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